Loading...Loading...Elevance Health Inc. ELV reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend and growth in CarelonRx product revenue related to members served.Related: Morgan Stanley Says Elevance Health’s Growth Attributed To Consistent Performance But Undervalued.Premiums fell 3.2% to $35.42 b ...